ctrl K

Aspire BioPharma Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.37

-0.05 (-12.74%)

At close: May 01, 2025, 3:59 PM

0.39

5.35%

Pre-market: May 02, 2025, 08:12 AM EDT

Aspire BioPharma Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	n/a	-242.62K	-96.92K	-163.87K	-76.3K	-65.53K	-90.27K
Interest Income	548.68K	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-11.97M	-242.62K	-96.92K	-163.87K	-76.3K	-65.53K	-90.27K
Net Income	-11.97M	-243.63K	-96.92K	-163.87K	-76.78K	-65.53K	-90.27K
Selling & General & Admin	2.55M	235.62K	86.42K	153.37K	65.8K	50.76K	79.77K
Research & Development	n/a	7K	10.5K	10.5K	10.5K	14.78K	10.5K
Other Expenses	-28K	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	2.52M	242.62K	96.92K	163.87K	76.3K	65.53K	90.27K
Interest Expense	891.62K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	-104.34K	16.68K	5K	43.83K	28.64K	n/a	11K
Cost & Expenses	2.52M	242.62K	96.92K	163.87K	76.3K	65.53K	90.27K
Income Tax Expense	-1.01K	1.01K	n/a	n/a	481.00	n/a	n/a
Shares Outstanding (Basic)	7.77M	45.94M	45.94M	45.94M	45.94M	45.94M	45.94M
Shares Outstanding (Diluted)	7.77M	45.94M	45.94M	45.94M	45.94M	45.94M	45.94M
EPS (Basic)	-0.26	-0.01	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.26	-0.01	-0.00	-0.00	-0.00	-0.00	-0.00
EBITDA	-8.64M	-242.62K	-96.92K	n/a	-76.3K	-65.53K	-90.27K
EBIT	-11.08M	-242.62K	-96.92K	-163.87K	-76.3K	-65.53K	-90.27K
Depreciation & Amortization	2.44M	n/a	n/a	163.87K	n/a	n/a	n/a